Should you buy AbbVie (abbv) in 2024?

Saving money takes time and effort. Fintel reports that on June 5, 2024, HSBC upgraded their outlook for AbbVie (NYSE:ABBV) from Hold to Buy. Analyst Price Forecast Suggests 15.08% Upside As of June 1, 2024, the average one-year price target for AbbVie is 186.58. The forecasts range from a low of 162.61 to a high of $217.35.

Why did AbbVie abbv shares rally 32% in the last trading session?

AbbVie ABBV shares rallied 3.2% in the last trading session to close at $161.24. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.8% loss over the past four weeks.

How do analysts evaluate AbbVie (ABV) stock?

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of AbbVie compared to the broader market. Price Targets: Delving into movements, analysts provide estimates for the future value of AbbVie's stock.